Viridiana C.

Inquirer
DISC Type : dc

Medical Director, Pipeline at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Viridiana is a pediatric hematologist and pharmaceutical physician serving as Medical Director, Pipeline at Alnylam Pharmaceuticals. Her career is rooted in global medical affairs, with significant experience at Sanofi and Sobi in rare hematological diseases like hemophilia. She completed a research fellowship at the University of Southern California.

She is a patient-focused professional who has volunteered with non-profit associations to increase disease awareness among patients and the medical community. Her international profile has enabled her to successfully manage multicultural relationships, and she is passionate about team collaboration and achieving results.

After dedicating over ten years to the hemophilia community, she has recently pivoted to a new professional focus within the platelets space.

Personality Overview

ROI Conscious

Upfront

Judgemental

They respond well to confident salespeople.  They care equally about the product and its potential impact. They can be nudged to make faster decisions by offering what they value.

Topics They Care About

Rare Hematology
Her career has focused on hematological diseases, including hemophilia, ITP (Immune Thrombocytopenia), and PNH (Paroxysmal Nocturnal Hemoglobinuria) across roles at Sanofi and Sobi.
Pharmaceutical Pipeline
Her current role as Medical Director, Pipeline at Alnylam Pharmaceuticals centers on the development of new products.
Hemophilia Community
She explicitly mentioned working for and with the hemophilia community for over a decade, showing a deep commitment to this area.

Media Appearances

Viridiana has no verified media appearances

Work History

12-2025
Medical Director, Pipeline at Alnylam Pharmaceuticals
7-2025 - 12-2025
Medical Program Lead ITP & PNH at Sobi - Swedish Orphan Biovitrum AB (publ)
11-2023 - 12-2025
Medical Program Lead - Rare Hematology (ITP) & Immunology (HLH) at Sobi - Swedish Orphan Biovitrum AB (publ)
8-2023 - 11-2023
Medical Program Lead - Rare Hematology (ITP) at Sobi - Swedish Orphan Biovitrum AB (publ)
11-2021 - 8-2023
Global Medical Lead, RBD - Hemophilia at Sanofi

Education

2014 - 2015
Research Fellow from University of Southern California
2009 - 2014
Pediatric Hematologist from Instituto Nacional de Pediatría

More Information

Social Presence :

Prographics :

Exp : 10 Location : Cambridge, Massachusetts, United States Job Level : Mid-senior Designation : Medical Director, Pipeline at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Viridiana

During A Call Or A Meeting

DO's

  • Tell them that you are there to help them create visible impact within their organization
  • Make sure that you you respond to any queries from them quickly
  • Be crisp while making the pitch

DONT's

  • Avoid repeating yourself or making generalizations
  • Do not give up if they are not convinced, try again with a different approach
  • Don’t try to be an alpha salesperson, give them equal space

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Viridiana is

  • Conviction in the product matters to them, followed by proof points and strong testimonials.
  • Will you ever get a clear answer from Viridiana

  • They may not be very forthcoming, but they will say no if needed.

Insights For Deal Planning

    How fast (or slow) will Viridiana move?

  • Their decision making speed is somewhere in the middle.
  • Can Viridiana take some risk or not?

  • They can take risks but after weighing up the pros and cons.

You And Viridiana

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.